![]() | Up a level |
Sokhela, Simiso, Venter, Willem D.F., Bosch, Bronwyn, Woods, Joana, McCann, Kaitlyn, Akpomiemie, Godspower, Chandiwana, Nomathemba, Mashabane, Nkuli, Tembo, Angela, Simmons, Bryony ORCID: 0000-0002-3207-9935, Lalla-Edward, Samanta, Siedner, Mark J., Sinxadi, Phumla, Hermans, Lucas, Fairlie, Lee, Vos, Alinda, Abrams, Elaine, Manne-Goehler, Jennifer M., Moorhouse, Michelle, Clayden, Polly, Norris, Shane, Qavi, Ambar, Chersich, Matthew, Masenya, Masebole, Arulappan, Natasha and Hill, Andrew
(2024)
Final 192-week efficacy and safety results of the ADVANCE trial, comparing 3 first-line antiretroviral regimens.
Open Forum Infectious Diseases, 11 (3).
ISSN 2328-8957
Sokhela, Simiso, Bosch, Bronwyn, Hill, Andrew, Simmons, Bryony ORCID: 0000-0002-3207-9935, Woods, Joana, Johnstone, Hilary, Madhi, Shabir, Qavi, Ambar, Ellis, Leah, Akpomiemie, Godspower, Bhaskar, Esther, Levi, Jacob, Falconer, Jonathan, Mirchandani, Manya, Perez Casas, Carmen, Moller, Karlien, Pilkington, Victoria, Pepperrell, Toby and Venter, Willem Daniel Francois
(2022)
Comparing prospective incident severe acute respiratory syndrome Coronavirus 2 infection rates during successive waves of Delta and Omicron in Johannesburg, South Africa.
Open Forum Infectious Diseases, 9 (12).
ISSN 2328-8957